SouthState’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$989 Hold
15
– – ﹤0.01% 1142
2026
Q2
$1.28K Hold
15
– – ﹤0.01% 1051
2026
Q1
$989 Hold
15
– – ﹤0.01% 1049
2025
Q4
$954 Hold
15
– – ﹤0.01% 1125
2025
Q3
$825 Hold
15
– – ﹤0.01% 1114
2025
Q2
$496 Buy
15
+5
+50% +$174 ﹤0.01% 1442
2025
Q1
$402 Buy
+10
New +$460 ﹤0.01% 1573

Other funds holding CYTK

SouthState's CYTK Position: Q3 2026 in Review

SouthState held its Cytokinetics (CYTK) position steady in Q3 2026 at 15 shares worth $989. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

SouthState first reported a position in CYTK in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.28K in Q2 2026. 348 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • SouthState held 15 shares of Cytokinetics worth $989 as of Q3 2026.
  • SouthState left its Cytokinetics share count unchanged in Q3 2026.
  • Cytokinetics made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1142 holding.
  • SouthState first reported a position in Cytokinetics in Q1 2025 and has held it in 7 quarters since.
  • SouthState's Cytokinetics position peaked at $1.28K in Q2 2026.
  • 348 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.